Diagnose Leukemia: Determine if the patient has CML. Guide Treatment: Assist doctors in selecting the appropriate therapy, such as tyrosine kinase inhibitors (TKIs). Monitor Treatment Response: Evaluate treatment effectiveness and assess whether the disease is progressing or regressing. Predict Outcomes: Help anticipate the likely course of the disease based on test results.

Patients with Chronic Myeloid Leukemia (CML): To confirm diagnosis and determine the type of disorder. Individuals Showing Symptoms Related to Leukemia: Such as severe fatigue, unexplained weight loss, or unusual bleeding. Patients Undergoing Leukemia Treatment: To monitor treatment response and determine effectiveness. Individuals with a Family History of Leukemia: To assess potential risks. Healthcare Providers or Specialists: To monitor disease progression after treatment and adjust the treatment plan as needed.

Severe Fatigue: Persistent tiredness and inability to perform daily activities. Unexplained Weight Loss: Significant weight loss without dieting or exercise. Recurrent Fever: Repeated elevated body temperature without a clear cause. Night Sweats: Excessive sweating during sleep. Unusual Bruising or Bleeding: Easy bruising or bleeding from the nose or gums. Bone or Joint Pain: Discomfort or pain in various parts of the body. Enlarged Spleen or Liver: Swelling or pain in the abdomen may be observed.

What is the BCR-ABL Test? It is a genetic test used to detect the fusion between the BCR and ABL genes, which is a marker for chronic myeloid leukemia (CML). How is the test performed? A sample of blood or bone marrow is taken, and polymerase chain reaction (PCR) is used to detect the genetic fusion. What are the normal levels for the test results? If no fusion is present, the result is negative. Any fusion indicates CML. Does the test require any special preparation? It usually does not require special preparation, but it is recommended to consult the doctor. What are the risks associated with the test? Potential risks are related to blood draw, such as bruising or localized pain, but these are generally minor. How long does it take to get the results? Results are usually available within a few days, but timing may vary depending on the laboratory. What are the treatment steps if the result is positive? Treatment may include tyrosine kinase inhibitors (TKIs), chemotherapy, or other therapies depending on the patient’s condition. Can the fusion return after treatment? In some cases, relapse can occur, so regular monitoring with the test is recommended.

Negative Result: Indicates no genetic fusion between the BCR and ABL genes, suggesting the absence of chronic myeloid leukemia (CML). Positive Result: Indicates the presence of the genetic fusion, suggesting a possible CML diagnosis. Assessment of Fusion Levels: If the fusion is present, its expression level is measured, ranging from low to high. Higher levels may indicate a more severe disease or lower response to treatment. Treatment Guidance: Treatment and monitoring depend on the fusion level. Higher fusion levels may require adjustments in the treatment plan.

BCR-ABL Gene Fusion Test | Lahalak Platform

Advanced genetic testing for BCR-ABL mutation to diagnose chronic myeloid leukemia and monitor the body's response to targeted therapy with high precision.

Prices starts from: 390.72 SAR

Scientific name: BCR-ABL Gene Fusion Test

BCR-ABL analysis is a genetic test used to detect the fusion between the BCR gene and the ABL gene, which is considered a key marker in the diagnosis of chronic myeloid leukemia (CML). This analysis is usually performed using polymerase chain reaction (PCR) technology to identify the presence of this fusion, helping assess the patient’s health stat...

BCR-ABL Gene Fusion Test - Leukemia Gene Fusion Test

Service type Genetic test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 390.72 SAR

Included Services

BCR-ABL Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Diagnose Leukemia: Determine if the patient has CML.
Guide Treatment: Assist doctors in selecting the appropriate therapy, such as tyrosine kinase inhibitors (TKIs).
Monitor Treatment Response: Evaluate treatment effectiveness and assess whether the disease is progressing or regressing.
Predict Outcomes: Help anticipate the likely course of the disease based on test results.

Recommended groups

Patients with Chronic Myeloid Leukemia (CML): To confirm diagnosis and determine the type of disorder.
Individuals Showing Symptoms Related to Leukemia: Such as severe fatigue, unexplained weight loss, or unusual bleeding.
Patients Undergoing Leukemia Treatment: To monitor treatment response and determine effectiveness.
Individuals with a Family History of Leukemia: To assess potential risks.
Healthcare Providers or Specialists: To monitor disease progression after treatment and adjust the treatment plan as needed.

Symptoms indicative

Severe Fatigue: Persistent tiredness and inability to perform daily activities.
Unexplained Weight Loss: Significant weight loss without dieting or exercise.
Recurrent Fever: Repeated elevated body temperature without a clear cause.
Night Sweats: Excessive sweating during sleep.
Unusual Bruising or Bleeding: Easy bruising or bleeding from the nose or gums.
Bone or Joint Pain: Discomfort or pain in various parts of the body.

FAQs

What is the BCR-ABL Test? It is a genetic test used to detect the fusion between the BCR and ABL genes, which is a marker for chronic myeloid leukemia (CML).
How is the test performed? A sample of blood or bone marrow is taken, and polymerase chain reaction (PCR) is used to detect the genetic fusion.
What are the normal levels for the test results? If no fusion is present, the result is negative. Any fusion indicates CML.
Does the test require any special preparation? It usually does not require special preparation, but it is recommended to consult the doctor.
What are the risks associated with the test? Potential risks are related to blood draw, such as bruising or localized pain, but these are generally minor.
How long does it take to get the results? Results are usually available within a few days, but timing may vary depending on the laboratory.

Normal Levels

Negative Result: Indicates no genetic fusion between the BCR and ABL genes, suggesting the absence of chronic myeloid leukemia (CML).
Positive Result: Indicates the presence of the genetic fusion, suggesting a possible CML diagnosis.
Assessment of Fusion Levels: If the fusion is present, its expression level is measured, ranging from low to high. Higher levels may indicate a more severe disease or lower response to treatment.
Treatment Guidance: Treatment and monitoring depend on the fusion level. Higher fusion levels may require adjustments in the treatment plan.